Who has been buying ICD stock?

1 distinct insiders have filed 10 disclosed insider purchases in ICD (040910), most recently on 2026-07-13. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does ICD have?

ICD has 10 buy-side and 0 sell-side disclosures on record, covering ₩60M ($42K) in total reported value, spanning 2024-04-04 to 2026-07-13.

Where does StockDrifts get ICD insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

ICD 040910

Company

아이씨디ICD

Insiders

Buys

Total Value

₩60M ($42K)

Avg Return

+0.94%

Last Filing

2026-07-13

ICD (040910) has 10 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩60M ($42K) in reported transaction value. The earliest filing StockDrifts holds for ICD is dated 2024-04-04; the most recent is 2026-07-13. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +0.94%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-08-07	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	₩4,190	+10.1%	₩11M ($7K)
2026-07-30	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.6K	₩3,720	+8.7%	₩10M ($7K)
2026-07-29	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.7K	₩3,810	+6.2%	₩10M ($7K)
2026-07-28	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.6K	₩3,850	+5.1%	₩10M ($7K)
2026-07-27	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.4K	₩4,020	+0.6%	₩10M ($7K)
2026-07-23	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.2K	₩4,070	-1.1%	₩9M ($6K)
2026-07-22	BUY	Market Buy	이승호 Seungho Lee	Internal director	285	₩4,060	-0.9%	₩1M ($804)
2026-07-21	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	₩4,065	-1.0%	₩10M ($7K)
2026-07-20	BUY	Market Buy	양장규 Yang Jang-gyu	Internal director	10.0K	₩3,990	+0.9%	₩40M ($28K)
2026-07-20	BUY	Market Buy	양장규 Yang Jang-gyu	Internal director	30.0K	₩3,990	+0.9%	₩120M ($83K)
2026-07-13	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.6K	₩3,865	+4.1%	₩10M ($7K)
2026-07-10	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	₩4,065	-1.0%	₩10M ($7K)
2026-07-09	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.6K	₩3,820	+5.4%	₩10M ($7K)
2026-07-08	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.7K	₩3,680	+3.8%	₩10M ($7K)
2026-07-07	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	₩3,845	-0.7%	₩10M ($7K)
2026-07-03	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	₩4,065	-6.0%	₩10M ($7K)
2026-07-01	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.3K	-	-	-
2026-06-30	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.4K	-	-	-
2026-06-26	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	-	-	-
2026-06-25	BUY	Market Buy	이승호 Seungho Lee	Internal director	2.5K	-	-	-
2026-03-30	BUY	신규선임	송화섭 Song Hwa-seop	Outside Director	15.6K	₩5,420	+9.6%	₩85M ($59K)
2026-03-30	BUY	신규선임	양장규 Yang Jang-gyu	Internal director	200.0K	₩5,420	+9.6%	₩1.1B ($753K)
2026-03-30	BUY	신규선임	양장규 Yang Jang-gyu	Internal director	80.0K	₩5,420	+9.6%	₩434M ($301K)
2026-03-30	BUY	신규선임	유의진 Euijin Yu	Outside Director	40.0K	₩5,420	+9.6%	₩217M ($151K)
2025-02-07	BUY	자사주상여금	김명호 Kim Myung-ho	vice president	2.2K	₩6,140	-19.2%	₩14M ($10K)
2025-02-07	BUY	자사주상여금	이승호 Seungho Lee	CEO	7.5K	₩6,140	-19.2%	₩46M ($32K)
2025-02-07	BUY	자사주상여금	강병조 Kang Byeong-jo	Managing Director	1.0K	₩6,140	-19.2%	₩6M ($4K)
2024-04-04	BUY	수증	이예지나 This is Jina	moving	1.5M	₩9,120	-45.6%	₩13.7B ($9.5M)
2024-04-04	SELL	증여	이승호 Seungho Lee	CEO	-1.5M	₩9,120	+45.6%	₩13.7B ($9.5M)

Frequently asked questions

Who has been buying ICD stock?: 1 distinct insiders have filed 10 disclosed insider purchases in ICD (040910), most recently on 2026-07-13. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does ICD have?: ICD has 10 buy-side and 0 sell-side disclosures on record, covering ₩60M ($42K) in total reported value, spanning 2024-04-04 to 2026-07-13.
Where does StockDrifts get ICD insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for ICD. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.